Morpholino

MO1-itga6a

ID

ZDB-MRPHLNO-121219-4

Name

MO1-itga6a

Previous Names

None

Target

itga6a (1)

Sequence

5' - AGCTCCATTGCCTGAAATGAATG - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

Translation-blocking MO.

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO1-itga6a

No data available

Phenotype

Phenotype resulting from MO1-itga6a

No data available

Phenotype of all Fish created by or utilizing MO1-itga6a

Phenotype	Fish	Conditions	Figures
vertical myoseptum malformed, abnormal	WT + MO1-itga6a + MO2-itga6a	standard conditions	Fig. 7 from Goody et al., 2012
myotome muscle cell increased length, abnormal	WT + MO1-itga6a + MO2-itga6a	standard conditions	Fig. 5 , Fig. 7 from Goody et al., 2012
myotome muscle tendon junction U-shaped, abnormal	WT + MO1-itga6a + MO2-itga6a	standard conditions	Fig. 5 from Goody et al., 2012
myotome decreased width, abnormal	WT + MO1-itga6a + MO2-itga6a	standard conditions	Fig. 4 from Goody et al., 2012
whole organism decreased length, abnormal	WT + MO1-itga6a + MO2-itga6a	standard conditions	Fig. 4 from Goody et al., 2012
vertical myoseptum U-shaped, abnormal	WT + MO1-itga6a + MO2-itga6a	standard conditions	Fig. 5 from Goody et al., 2012
myotome muscle tendon junction malformed, abnormal	WT + MO1-itga6a + MO2-itga6a	standard conditions	Fig. 4 , Fig. 5 from Goody et al., 2012
myotome muscle tendon junction U-shaped, abnormal	WT + MO1-itga6a + MO2-itga6a + MO9-tp53	standard conditions	Fig. 5 from Goody et al., 2012
vertical myoseptum U-shaped, abnormal	WT + MO1-itga6a + MO2-itga6a + MO9-tp53	standard conditions	Fig. 5 from Goody et al., 2012
myotome muscle cell increased length, abnormal	WT + MO1-itga6a + MO2-itga6a + MO9-tp53	standard conditions	Fig. 5 from Goody et al., 2012
myotome muscle tendon junction malformed, abnormal	WT + MO1-itga6a + MO2-itga6a + MO9-tp53	standard conditions	Fig. 5 from Goody et al., 2012
myotome muscle tendon junction malformed, abnormal	lamc1^{wi390Tg/wi390Tg} + MO1-itga6a + MO2-itga6a	standard conditions	Fig. 4 from Goody et al., 2012
trunk decreased length, abnormal	lamc1^{wi390Tg/wi390Tg} + MO1-itga6a + MO2-itga6a	standard conditions	Fig. 4 from Goody et al., 2012
post-vent region decreased length, abnormal	lamc1^{wi390Tg/wi390Tg} + MO1-itga6a + MO2-itga6a	standard conditions	Fig. 4 from Goody et al., 2012
vertical myoseptum U-shaped, abnormal	WT + MO1-dag1 + MO1-itga6a + MO2-itga6a	standard conditions	Fig. 5 from Goody et al., 2012
vertical myoseptum U-shaped, abnormal	WT + MO1-dag1 + MO1-itga6a + MO2-itga6a	chemical treatment: NAD(+)	Fig. 5 from Goody et al., 2012
myotome muscle tendon junction U-shaped, abnormal	WT + MO1-dag1 + MO1-itga6a + MO2-itga6a	standard conditions	Fig. 5 from Goody et al., 2012
myotome muscle tendon junction U-shaped, abnormal	WT + MO1-dag1 + MO1-itga6a + MO2-itga6a	chemical treatment: NAD(+)	Fig. 5 from Goody et al., 2012
myotome muscle cell degenerate, abnormal	WT + MO1-dag1 + MO1-itga6a + MO2-itga6a	standard conditions	Fig. 5 from Goody et al., 2012
myotome muscle cell degenerate, abnormal	WT + MO1-dag1 + MO1-itga6a + MO2-itga6a	chemical treatment: NAD(+)	Fig. 5 from Goody et al., 2012
vertical myoseptum malformed, abnormal	mai1Tg + MO1-itga6a + MO2-itga6a	standard conditions	Fig. 7 from Goody et al., 2012
myotome muscle cell increased length, abnormal	mai1Tg + MO1-itga6a + MO2-itga6a	standard conditions	Fig. 7 from Goody et al., 2012

Citations